The strengthened cash position will support continued advancement of the Company’s pivotal Phase 3 SERENITY At-Home trial. The trial is designed to evaluate the safety of BXCL501. “We are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback